Bitter orange (Citrus aurantium L.) extract subchronic 90-day safety study in rats
Bitter orange (Citrus aurantium L.) extracts are widely used in dietary supplements and bitter oranges are used in various juices and food products. p-Synephrine, the primary active constituent, comprises approximately 90% of total protoalkaloids. This study, performed per OECD 408 guidance, examine...
Main Authors: | N.S. Deshmukh, S.J. Stohs, C.C. Magar, A. Kale, B. Sowmya |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-01-01
|
Series: | Toxicology Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S221475001730094X |
Similar Items
-
Assessment of the adverse event reports associated with Citrus aurantium (bitter orange) from April 2004 to October 2009
by: Sidney J. Stohs
Published: (2010-10-01) -
Comparative investigation of the sweet and bitter orange essential oil (Citrus sinensis and Citrus aurantium)
by: Sanja Kostadinovic, et al.
Published: (2005-10-01) -
A Review of the Human Clinical Studies Involving Citrus aurantium (Bitter Orange) Extract and its Primary Protoalkaloid p-Synephrine
by: Sidney J. Stohs, Harry G. Preuss, Mohd Shara
Published: (2012-01-01) -
Canning of the juice of the bitter orange (C. Aurantium)
by: Roghani, Maruf Shah
Published: (2011) -
Citrus aurantium (bitter orange) seeds oil: pharmacognostic, anti-inflammatory and anti-nociceptive properties
by: Azadeh Hamedi, et al.
Published: (2019-09-01)